Phase I trial of COL 172, an extended-release formulation of oxymorphone

Trial Profile

Phase I trial of COL 172, an extended-release formulation of oxymorphone

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Mar 2010

At a glance

  • Drugs Oxymorphone (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top